A practical review of the emerging direct anticoagulants, laboratory monitoring, and reversal agents

Stephanie A. Joppa, Justin Salciccioli, Jill Adamski, Salma Patel, Waldemar Wysokinski, Robert McBane, Farah Al-Saffar, Heidi Esser, Fadi Elias Shamoun

Research output: Contribution to journalReview articlepeer-review

Abstract

Millions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now several DOACs are available and their use has become more prevalent in recent years. In spite of this increased use, many physicians remain reluctant to prescribe DOACs due to concerns about bleeding and reversibility.

Original languageEnglish (US)
Article number29
JournalJournal of Clinical Medicine
Volume7
Issue number2
DOIs
StatePublished - Feb 11 2018

Keywords

  • Anticoagulants
  • Reversal agents
  • Serum levels

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'A practical review of the emerging direct anticoagulants, laboratory monitoring, and reversal agents'. Together they form a unique fingerprint.

Cite this